Gene Hung

11.3k total citations · 6 hit papers
69 papers, 8.6k citations indexed

About

Gene Hung is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Gene Hung has authored 69 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 15 papers in Genetics. Recurrent topics in Gene Hung's work include Genetic Neurodegenerative Diseases (16 papers), RNA Research and Splicing (13 papers) and Neurogenetic and Muscular Disorders Research (12 papers). Gene Hung is often cited by papers focused on Genetic Neurodegenerative Diseases (16 papers), RNA Research and Splicing (13 papers) and Neurogenetic and Muscular Disorders Research (12 papers). Gene Hung collaborates with scholars based in United States, Germany and Canada. Gene Hung's co-authors include C. Frank Bennett, Frank Rigo, Adrian R. Krainer, Yimin Hua, Kentaro Sahashi, Gayatri Arun, David L. Spector, Marco A. Passini, Jeff Hsu and A. Robert MacLeod and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Gene Hung

67 papers receiving 8.5k citations

Hit Papers

The Noncoding RNA MALAT1 ... 1997 2026 2006 2016 2012 2016 1997 2012 2011 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gene Hung 6.6k 2.2k 2.2k 1.5k 943 69 8.6k
Debra Compton 5.8k 0.9× 562 0.2× 1.9k 0.9× 1.3k 0.8× 1.3k 1.4× 13 8.0k
Atsushi Natsume 2.4k 0.4× 1.5k 0.6× 1.1k 0.5× 306 0.2× 1.3k 1.4× 189 5.2k
Anna Lasorella 4.3k 0.7× 1.2k 0.5× 1.6k 0.7× 209 0.1× 1.6k 1.7× 92 6.8k
Lauren A. Langford 2.9k 0.4× 959 0.4× 579 0.3× 585 0.4× 867 0.9× 70 5.4k
Paul A. Northcott 6.4k 1.0× 4.1k 1.8× 2.0k 0.9× 213 0.1× 1.1k 1.2× 120 8.6k
Martin Friedlander 5.6k 0.8× 424 0.2× 1.2k 0.6× 677 0.4× 789 0.8× 144 9.2k
Toshihide Iwashita 3.5k 0.5× 859 0.4× 597 0.3× 660 0.4× 1.3k 1.4× 106 7.3k
O. D. Wiestler 2.1k 0.3× 1.4k 0.6× 632 0.3× 620 0.4× 617 0.7× 100 4.8k
Bianca Pollo 1.9k 0.3× 2.5k 1.1× 772 0.4× 318 0.2× 1.3k 1.4× 167 5.4k
Silvia Marino 4.6k 0.7× 826 0.4× 722 0.3× 414 0.3× 1.4k 1.4× 131 6.3k

Countries citing papers authored by Gene Hung

Since Specialization
Citations

This map shows the geographic impact of Gene Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene Hung more than expected).

Fields of papers citing papers by Gene Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene Hung. The network helps show where Gene Hung may publish in the future.

Co-authorship network of co-authors of Gene Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Gene Hung. A scholar is included among the top collaborators of Gene Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene Hung. Gene Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Newbury, Lucy J., et al.. (2019). Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy. Scientific Reports. 9(1). 14010–14010. 20 indexed citations
2.
Soriano, Armand, Lawrence Bai, Todd Machemer, et al.. (2017). The Distinct and Cooperative Roles of Toll-Like Receptor 9 and Receptor for Advanced Glycation End Products in Modulating In Vivo Inflammatory Responses to Select CpG and Non-CpG Oligonucleotides. Nucleic Acid Therapeutics. 27(5). 272–284. 21 indexed citations
3.
Moore, Lauren R., Gautam Rajpal, Danielle Gattis, et al.. (2017). Evaluation of Antisense Oligonucleotides Targeting ATXN3 in SCA3 Mouse Models. Molecular Therapy — Nucleic Acids. 7. 200–210. 90 indexed citations
4.
Finkel, Richard S., Claudia A. Chiriboga, Jiri Vajsar, et al.. (2016). Interim Results of a Phase 2 Clinical Study of Nusinersen (ISIS-SMNRx) in Patients with Infantile-Onset Spinal Muscular Atrophy (P5.004). Neurology. 86(16_supplement). 5 indexed citations
5.
Grossman, Tamar R., Lisa Hettrick, Robert B. Johnson, et al.. (2015). Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice. Immunobiology. 221(6). 701–708. 27 indexed citations
6.
Burel, Sebastien A., Christopher E. Hart, Todd Machemer, et al.. (2015). Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Nucleic Acids Research. 44(5). 2093–2109. 148 indexed citations
7.
Scoles, Daniel R., Gene Hung, Lance Pflieger, et al.. (2014). Treatment Of Spinocerebellar Ataxia Type 2 (SCA2) with MOE Antisense Oligonucleotides (S47.006). Neurology. 82(10_supplement). 1 indexed citations
8.
Lieberman, Andrew P., Zhigang Yu, Sue Murray, et al.. (2014). Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy. Cell Reports. 7(3). 774–784. 128 indexed citations
9.
Rigo, Frank, Seung Chun, Daniel A. Norris, et al.. (2014). Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 350(1). 46–55. 213 indexed citations
10.
Gutschner, Tony, Monika Hämmerle, Moritz F. Eissmann, et al.. (2012). The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells. Cancer Research. 73(3). 1180–1189. 1307 indexed citations breakdown →
11.
Kordasiewicz, Holly, Lisa M. Stanek, Edward V. Wancewicz, et al.. (2012). Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis. Neuron. 74(6). 1031–1044. 563 indexed citations breakdown →
12.
Hung, Gene, Kurt Giles, Chris Black, et al.. (2012). Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice. Molecular Therapy — Nucleic Acids. 1. e9–e9. 36 indexed citations
13.
Burel, Sebastien A., Todd Machemer, Hiroki Kato, et al.. (2012). Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response. Journal of Pharmacology and Experimental Therapeutics. 342(1). 150–162. 25 indexed citations
14.
Carroll, Jeffrey B., Simon C. Warby, Amber L. Southwell, et al.. (2011). Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin. Molecular Therapy. 19(12). 2178–2185. 225 indexed citations
15.
Benson, Merrill D., Richard Smith, Gene Hung, et al.. (2010). Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment. Amyloid. 17(2). 43–49. 34 indexed citations
16.
Kim, Dong‐Hyun, Bethany Fitzsimmons, Camilla I. Svensson, et al.. (2008). Inhibition of spinal cytosolic phospholipase A2 expression by an antisense oligonucleotide attenuates tissue injury-induced hyperalgesia. Neuroscience. 154(3). 1077–1087. 16 indexed citations
17.
Chadee, Deborah, Da-Zhong Xu, Gene Hung, et al.. (2006). Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein. Proceedings of the National Academy of Sciences. 103(12). 4463–4468. 78 indexed citations
18.
Hung, Gene, et al.. (2002). Immunohistochemistry study of human vestibular nerve schwannoma differentiation. Glia. 38(4). 363–370. 25 indexed citations
19.
Press, Michael F., Leslie Bernstein, P. Thomas, et al.. (1997). HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.. Journal of Clinical Oncology. 15(8). 2894–2904. 643 indexed citations breakdown →
20.
Press, Michael F., Malcolm C. Pike, Gene Hung, et al.. (1994). Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.. PubMed. 54(21). 5675–82. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026